Moreover, recent publications demonstrate that acquired somatic mutations in TERT and α-thalassemia/mental retardation syndrome X-linked protein (ATRX) can affect telomere maintenance in tumor cells and are important in glioma development and prognosis [42,43,44,45]. The gene discussed is ATRX; the disease is central nervous system cancer.